These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11334029)

  • 21. The growth hormone IGF-I axis in dilated cardiomyopathy.
    Jenkins RC; Ross RJ
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):415-6. PubMed ID: 10468899
    [No Abstract]   [Full Text] [Related]  

  • 22. Somatropin (mammalian cell-derived recombinant human growth hormone) for HIV-associated wasting.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Oct; 3(10):30-5. PubMed ID: 11364744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Although both rhGh and rhIGF-I have the potential to provide clinical benefit, each also has the potential to produce unwanted side-effects.
    Le Roith D
    Growth Horm IGF Res; 1999 Apr; 9(2):83. PubMed ID: 10373340
    [No Abstract]   [Full Text] [Related]  

  • 24. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
    Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
    Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis and the growth hormone-insulin-like growth factor axis.
    Geusens PP; Boonen S
    Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone.
    Gil-Ad I; Klinger B; Pertzelan A; Erster B; Silbergeld A; Talpaz H; Laron Z
    J Endocrinol Invest; 1992 Nov; 15(10):735-9. PubMed ID: 1362733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone deficiency in adults: characteristics and response to growth hormone replacement.
    Lieberman SA; Hoffman AR
    J Pediatr; 1996 May; 128(5 Pt 2):S58-60. PubMed ID: 8627472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of insulin-like growth factors and growth hormone in reversing catabolic states.
    Clemmons DR; Underwood LE
    Horm Res; 1992; 38 Suppl 2():37-40. PubMed ID: 1292979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-I/IGFBP-1 as an index for discrimination between responder and nonresponder to recombinant human growth hormone in malnourished uremic patients on hemodialysis.
    Shinobe M; Sanaka T; Nihei H; Sugino N
    Nephron; 1997; 77(1):29-36. PubMed ID: 9380235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity to Growth Hormone, Standardization of IGF-I Measurements. Proceedings of the 5th KIGS/KIMS Expert Meeting on Growth and Growth Disorders. Windsor, United Kingdom. February 2-3, 2001.
    Horm Res; 2001; 55 Suppl 2():1-110. PubMed ID: 11775586
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone treatment for patients with renal failure.
    Kopple JD; Brunori G; Leiserowitz M; Mattimore C; Hirschberg R
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):468-74. PubMed ID: 1895546
    [No Abstract]   [Full Text] [Related]  

  • 34. High-affinity growth hormone (GH)-binding protein (GHBP), body fat mass, and insulin-like growth factor-binding protein-3 predict the GHBP response to GH therapy in adult GH deficiency syndrome.
    Roelen CA; Koppeschaar HP; de Vries WR; Doerga ME; Snel YE; Bol E; Zelissen PM; Thijssen JH; Blankenstein MA
    Metabolism; 1999 Mar; 48(3):314-8. PubMed ID: 10094106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone therapy in elderly people.
    Lancet; 1991 May; 337(8750):1131-2. PubMed ID: 1674018
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy with recombinant growth hormone].
    Wabitsch M
    MMW Fortschr Med; 2007 Jun; 149(23):41-3. PubMed ID: 18062578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone insensitivity: diagnostic and therapeutic approaches.
    Kurtoğlu S; Hatipoglu N
    J Endocrinol Invest; 2016 Jan; 39(1):19-28. PubMed ID: 26062520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
    Patel L; Webb NJ; Bradbury MG; Zaman N; Smith P; Lewis MA; Postlethwaite RJ; Price DA; Clayton PE
    Pediatr Nephrol; 2002 Aug; 17(8):643-7. PubMed ID: 12185474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenicity and efficacy of authentic sequence recombinant human growth hormone (somatropin): first-year experience in the United Kingdom.
    Buzi F; Buchanan CR; Morrell DJ; Preece MA
    Clin Endocrinol (Oxf); 1989 May; 30(5):531-8. PubMed ID: 2691122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Growth hormone, IGF and bone metabolism in adults].
    Bonjour JP; Chevalley T; Ammann P; Schurch MA; Rizzoli R
    Ann Endocrinol (Paris); 1996; 57(3):147-9. PubMed ID: 8949406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.